-
Back pain in Parkinson’s disease: an underestimated problem
-
Backward Fall Protection Garment for patients of PSP and other Parkinsonian Syndromes.
-
Balance rehabilitation for people with mild to moderate Parkinson’s disease: A scoping review of dual-task training interventions and outcome measures
-
Ballistic single-joint arm movements in levodopa-induced dyskinesias in Parkinson´s disease.
-
Baseline and six months change in cortical perfusion in a mesenchymal stem cell trial for Parkinson’s disease
-
Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease
-
BASELINE OLFACTION TESTING IN PARKINSON’S DISEASE PATIENTS IS CORRELATED WITH LONG-TERM DOPAMINERGIC DENERVATION IN STRIATAL SUB-REGIONS: LONGITUDINAL DATA FROM THE PPMI STUDY.
-
Be aware of pitfalls: Bioinformatic analysis of Cas9-targeted Nanopore sequencing of the RFC1 repeat in CANVAS
-
Behavioral effects of stimulated dopamine release and D2-like receptor displacement in Parkinson’s patients with impulse control disorder
-
Belly Dancer’s Dyskinesia with Systemic Lupus Erythematosus: A Case Report
-
Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE
-
Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism
-
Beta synchronization of the subthalamic nucleus during self-initiated and externally generated movement in parkinsonian patients in OFF and ON states
-
Beta-antagonists and risk of Parkinson’s disease: Meta-analysis of real-world evidence studies
-
Bilateral focused ultrasound thalamotomy for essential tremor (BEST-FUS trial): safety and efficacy proof of principle
-
BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A PATIENT WITH PARKINSON DISEASE AND INTOLERANCE TO STANDARD ANTIPARKINSONIAN DRUGS – A CASE REPORT
-
Biofluid Biomarkers in Prodromal Parkinson’s Disease
-
Biomarker candidates – Peptides identified to be differentially abundant in cerebrospinal fluid of patients with Parkinson´s disease
-
Blepharospasm – a network disorder
-
Blindness analyses in STEADY-PD3: a phase III placebo-controlled double-blind randomized trial of Isradipine as a disease modifying agent in early Parkinson Disease
-
Blood-based circulating microRNAs for discriminating between Parkinson’s disease subtypes
-
Body mass index and incidence of Parkinson’s disease in French women from the E3N cohort study
-
Both online and in-person JOBGRIP group training for people with Parkinson’s with paid employment is acceptable and perceived to be valuable
-
Botulinum injections for idiopathic cervical dystonia: a longitudinal study
-
Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience
-
Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up
-
Brain activity of the emotional circuit in Parkinson’s disease patients with freezing of gait
-
Brain MRI Cortical Atrophy correlation to clinical onset in Huntington’s Disease
-
Brain MRI morphological changes in different self-reported sleep disturbances in PD patients
-
Brain SPECT in Patients with Akinetic-Rigid Syndrome Secondary to Radiotherapy
-
Brainstem planimetry in Parkinson’s disease with REM behaviour disorder.
-
Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)
-
Building a Global Parkinson’s Genetics Program (GP2): Clinical Cohorts Integration Working Group
-
Burden of illness among US Medicare beneficiaries with late-onset Huntington’s disease
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org